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BACKGROUND: For a child to develop acute leukaemia (AL), environmental exposure may not be sufficient: interaction with a
susceptibility factor to the disease, such as Down syndrome (DS), may also be necessary. We assessed whether breastfeeding and
early infection were associated with the risk of developing AL in children with DS.
METHODS: Children with DS in Mexico City, and either with or without AL, were the cases (N¼57) and controls (N¼218),
respectively. Population was divided in children with AL and with acute lymphoblastic leukaemia (ALL) and also in children p6 and
46 years old.
RESULTS: Breastfeeding and early infections showed moderate (but not significant) association for AL, whereas hospitalisation by
infection during the first year of life increased the risk: odds ratios (confidence interval 95%) were 0.84 (0.43–1.61), 1.70 (0.82–3.52);
and 3.57 (1.59–8.05), respectively. A similar result was obtained when only ALL was analysed.
CONCLUSION: We found that breastfeeding was a protective factor for developing AL and ALL, and during the first year of life,
infections requiring hospitalisation were related to a risk for developing the disease in those children with DS 46 years of age. These
data do not support the Greaves’s hypothesis of early infection being protective for developing ALL.
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Worldwide, acute leukaemia (AL) is the commonest type of
childhood malignancy with an annual incidence of 30–50 cases
per million children (Curado et al, 2007); Mexico City has one of
the highest rates, at 58.4 cases per million (Mejia-Arangure et al,
2005a). Among the identified risk factors, individuals with Down
syndrome (DS) below 20 years of age have 10- to 20-fold greater
risk of developing AL compared with the general population
(Robison, 1992; Ross et al, 2005).
According to the Greaves’ hypotheses, late contact with
infectious agents may lead to an abnormal or aberrant immune
response that favors the development of acute lympho-
blastic leukaemia (ALL) (Greaves, 2005). Correspondingly, early
infections have a protective effect in ALL by promoting the
physiological maturation of the immune system, whereas late
infections promote an excessive proliferation of the lymphocytes
(McNally and Eden, 2004; Menegaux et al, 2004; Greaves, 2006;
O’Connor and Boneva, 2007).
Children with DS, due to their increased susceptibility to AL,
provide a natural and valuable model for evaluating the interaction
between the susceptibility for AL and the environment. In this
study, we assessed whether breastfeeding and early infection were
associated with the risk of developing AL in children with DS.
Mother’s milk is an important modulator of the immune response
in infants because, while by providing the child with antibodies
and immune cells, it can also be a source of transmission of
infectious agents (MacArthur et al, 2008). Received 6 May 2009; revised 7 July 2009; accepted 20 July 2009
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A case–control study was performed. All cases of DS and AL under
19 years of age diagnosed with AL during the period 1998–2006
were included in this study. These institutions treat children
under this age and the major number of cases of ALL occurred
during this age (Hasle et al, 2000). They were drawn from the
six participating public institutions that treat children with cancer
in Mexico City, under the auspices of the Instituto Mexicano de
Seguro Social (IMSS), Instituto de Seguridad Social al Servicio de
los Trabajadores del Estado (ISSSTE) and Secretarı ´a de Salud (SS).
Each diagnosis of AL was confirmed by means of a bone marrow
aspirate and clinical study of karyotype.
Children with DS are enrolled in two types of institution in Mexico
City. The Centres of Multiple Attention (CMA) and Specialized
Centres that provide special education exclusively to children with DS.
The controls for this study were drawn from three of those Specialized
Centres: (1) John Langdon Down Institute, (2) Centro de Terapia
Educativa CTDUCA and (3) Centro de Educacion Down Asociacion
Civil CEDAC, where the karyotype is a requisite for admission of a
child. Of such children under 19 years of age in the above-mentioned
Specialized Centres, 78% were included in this study. These centres
accept children from any part of Mexico City and if any child develops
AL, care would be provided by one of the hospitals serving as sources
of the cases. It should be noted that, although there are 76 other CMA
in Mexico City that provide special care for children with diverse
disabilities, including DS, none of these children were included in this
study because their karyotypes had not been documented.
To collect the information required for the questionnaire (QMOD
website; National Cancer Institute, 1998) for both groups, nurses went
to the hospitals and institutions of special education, after obtaining a
letter of informed consent from the parents. Parents who agreed to
p a r t i c i p a t ew e r et h e ni n t e r v i e w e dindividually about child’s medical
history: birth weight of the child; breastfeeding; infections during the
first year of life of the child (upper respiratory tract infections,
bronchopneumonia, pneumonias, gastrointestinal infections, etc.);
infections that required hospitalisation during the first year of life;
antecedent of cardiovascular disease in the child; family history of
cancer; personal habits of the parents, such as smoking and alcohol
consumption; and age of the mother at delivery and socio-
demographic aspects. The stacking level was used as a proxy for
socio-economic status, and it was calculated according to the number
of persons per room in a household. Classification, using the criteria
of Bronfman et al (1988) was as follows: not crowded (up to 1.5), semi
crowded (between 1.6 and 3.5) and crowded (3.6 and more). Low
socio-economic level included both semi crowded and crowded.
Statistical analyses
All the leukaemias were included in the analysis. The odds ratio
(OR) and the 95% confidence intervals (CIs) were calculated
in measuring the relation between breastfeeding, early infections,
and hospitalisation due to infections and the control variables
and AL in children with DS. Each of the independent variables
(breastfeeding, early infections and hospitalisation due to
infections) was stratified for each one of the control variables in
order to control for confounding factors that may modify the
effect. The ORs were estimated using an unconditional logistic
regression analysis, controlling for the sex and age of the child,
birth weight of the child, firstborn child, standard of living
and cardiovascular diseases. A logistic regression model was also
applied to the group of children with ALL. The statistical package
used for this analysis was SPSS version 16.0 (2008 SPSS Inc.,
Chicago, IL, USA).
RESULTS
Of the 57 cases (1998–2006) of children with DS and leukaemia,
45 (79. 2%) had ALL; the remainder having acute myeloblastic
leukaemia (Table 1). The average age of the cases at diagnosis of
AL, and of the controls, at the time of interview with the parents,
were 106 and 82 months, respectively (P¼0.04). Of the 57 AL
cases, 50 were aged 0–14 years, as were 39 of the 45 ALL cases. The
birth weight median of the cases and controls was 2700 and 2500g,
respectively (P¼0.36) (Table 2). Neither the number of the
hospitalisations nor the length of the stay differed between cases
and controls, but age at first hospitalisation for infection differed
Table 1 Descriptive analysis of the variables for children with Down syndrome, residing in Mexico City (1998–2006), included in this study
Cases (N¼57) Controls (N¼218)
Variables N % N % OR (CI 95%)
Type of leukaemia
ALL 45 79.2 NA NA NA
AML 12 20.8 NA NA NA
Maternal breastfeeding 36 63.2 142 65.1 0.92 (0.50–1.69)
Family history of cancer 33 57.9 104 47.7 1.51 (0.84–2.72)
Male 27 47.4 117 53.7 0.78 (0.43–1.39)
Firstborn child 8 14.0 73 33.5 0.32 (0.15–0.72)
Child’s weight at birth 42500g 39 68.4 127 58.3 1.55 (0.83–2.89)
Infection during child’s first year of life 16 28.1 56 25.7 1.13 (0.59–2.17)
Hospitalisation for infection during child’s first year of life 14 24.5 29 13.3 2.22 (1.08–4.58)
Gastrointestinal illness 3 20.0 7 24.1 0.943*
Respiratory tract infection 9 60.0 16 55.2
Other 3 20.0 6 20.7
Presence of allergies in child 17 29.8 75 34.4 0.81 (0.43–1.52)
Low standard of living 45 78.9 153 70.2 1.59 (0.79–3.21)
Cardiovascular illness in child 7 12.3 57 26.1 0.39 (0.17–0.92)
Age of mother at delivery 435 years 22 38.6 76 34.9 1.17 (0.64–2.14)
Smoking by father during wife’s pregnancy 32 56.1 128 58.7 0.90 (0.50–1.62)
Smoking by mother during pregnancy 15 26.3 63 28.9 0.88 (0.45–1.70)
Alcohol consumption by father before pregnancy 52 91.2 187 85.8 1.72 (0.64–4.65)
Alcohol consumption by mother during pregnancy 30 52.6 164 75.2 0.36 (0.20–0.67)
ALL¼acute lymphoblastic leukaemia; AML¼acute myeloblastic leukaemia; CI¼confidence intervals; NA¼not applicable; OR¼odds ratio. *P-value.
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life was significantly related to the development of AL (OR¼2.22
(CI 95% 1.08–4.58)). Neither family history of cancer (OR¼1.51
(CI 95% 0.84–2.72)) nor birth weight 42500g (OR¼1.55 (CI 95%
0.83–2.89)) showed a significant effect. When the maternal
breastfeeding lasted p6 months during the first months of life,
the OR was 0.17 (CI 95% 0.04–0.62); when breastfeeding lasted X7
months, the OR was 0.79 (CI 95% 0.25–2.46). The results of the
unconditional logistical regression analysis showed an OR of 0.84
(CI 95% 0.43–1.61) for breastfeeding and AL risk, and an OR of
1.70 (CI 95% 0.82–3.52) for infections during the first year of life
and the risk of AL, both of which were not significant. However,
the risk of developing AL was greater if the child had been
hospitalised during the first year of life, with an OR of 3.57 (CI 95%
1.59–8.05) on this model, adjusted for control variables (Table 3).
The results were similar when we analysed only children with ALL
(Table 3).
In subsequent analyses of children with ALL, the study
population was divided according to the average age of onset of
the leukaemia into p6 years (p72 months) and 46 years (472
months), and also by socio-economic level (low and high).
Breastfeeding for p6 months of life was protective for AL but
not for a longer period, or, as in the case for the children from low
socio-economic background, even seemed as a risk factor (Table 4).
In this analyses, hospitalisation during the first year of life
remained as a risk factor for children aged 46 years.
DISCUSSION
This is the first study in Mexico City of breastfeeding and
infections in relation to the development of AL in children with
DS. We found that children who had been breastfed p6 months
had a lower risk of developing AL, independent of their socio-
Table 2 Descriptive analysis of the continuous variables for children with Down syndrome, residing in Mexico City (1998–2006), included in this study
Cases (N¼57) Controls (N¼218)
Variable Median Minimum-maximum Median Minimum-maximum P-value
a
Maternal breastfeeding (in months) 5.69 0–36 3.77 0–48 0.78
Age of child (in months) at the time of diagnosis
b,
or at time of interview of parents
c
106 1–227 82 1–227 0.04
Child’s weight at birth (g) 2700 1200–4000 2500 900–4100 0.36
Age of mother at delivery 32 16–43 33 15–46 0.47
Number of hospitalisation by infections in child 1.00 1–3 1.00 1–12 0.88
Time (in days) for hospitalisation by infections in child 5 1–20 7 2–30 0.35
Age at hospitalisation by infection in child (months) 7 4.03 4 3.79 0.03
d
aMann–Whitney U-test.
bCases.
cControls.
dStudent’s t-test.
Table 3 Logistic regression model for maternal breastfeeding and early infections in children with Down syndrome in the whole population of the study
and in children just with acute lymphoblastic leukaemia
Whole population with AL Children with ALL
Variables OR
a CI 95% OR
a CI 95%
Maternal breastfeeding 0.84 0.43–1.61 0.74 0.36–1.49
Breastfeeding p6 months 0.49 0.23–1.04 0.49 0.21–1.11
Breastfeeding X7 months 1.45 0.67–3.11 1.33 0.57–3.09
Hospitalisation for infection during the child’s first year of life 3.57 1.59–8.05 3.45 1.37–8.66
Infection during the child’s first year of life 1.70 0.82–3.52 1.45 0.64–3.30
AL¼acute leukaemia; ALL¼acute lymphoblastic leukaemia; CI¼confidence intervals; OR¼odds ratio.
aThe model was adjusted for the following variables: sex, weight at birth
o2500g, age of child, firstborn child, low standard of living and cardiovascular diseases.
Table 4 Logistic regression model for maternal breastfeeding and early infections for children with Down syndrome by age at the time of diagnosis of
acute lymphoblastic leukemia and by low socio-economic level
All the children Low socio-economic level
p72 months of age 472 months of age p72 months of age 472 months of age
Variables OR
a CI 95% OR
a CI 95% OR
b CI 95% OR
b CI 95%
Maternal breastfeeding 0.37 0.10–1.33 0.93 0.38–2.30 0.50 0.12–2.17 1.76 0.54–5.73
Breastfeeding p6 months 0.17 0.03–0.88 0.67 0.24–1.85 0.19 0.30–1.26 0.90 0.23–3.48
Breastfeeding X7 months 0.81 0.19–3.44 1.68 0.54–5.21 1.24 0.24–6.55 5.71 1.30–25.05
Hospitalisation for infection during the first year of life 2.09 0.40–10.78 7.58 2.09–27.54 2.29 0.40–13.23 8.20 1.55–43.26
Infection during the first year of life 0.80 0.18–3.60 3.18 1.01–9.97 0.70 0.14–3.47 5.12 1.05–24.89
CI¼confidence intervals; OR¼odds ratio.
aThe model was adjusted for the following variables: sex, weight at birth o2500g, age of child, firstborn child, low standard of living
and cardiovascular diseases.
bThe model was adjusted for the same variables as model one, but the variable, ‘socio-economic level’, was excluded.
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early infections overall were not related to AL, those during the
first year, that were severe enough to warrant hospitalisation were
associated with increased risk of AL. This was notably higher for
children 46 years of age than for those p6 years.
The measurement of infections during the first year of life using
a questionnaire, may introduce errors, given that the considerable
interval since the events had occurred and the interview of the
mother. The median age between cases and controls was 8.5 and
almost 7 years, respectively; for this the precision of recalling the
infections during the first year or the duration of breastfeeding is
low, but this situation was similar among the two populations.
Therefore, proxy measurements of infective exposures (such as the
number of children with whom they live, or nursery school
attendance) have been recommended during this period of life
(McNally and Eden, 2004). The medical records of each patient
provide the best assessment of infection during the first year of life
(Roman et al, 2007). In this study, we asked about infections
during the first year of life, and whether hospitalisation had been
required. The fact that, in almost 80% of the cases, the parents
could name the pathology for which the child was hospitalised,
gave us a certain degree of confidence in the information supplied.
The size of the sample studied is smaller than those reported in
other studies in children with DS; however, it should be mentioned
that (1) this study consisted of 100% of the cases of children
diagnosed with DS and AL under 19 years of age, who were listed
in the Registry of AL in Mexico City during the study period and
(2) in this period, the number of cases with DS by year in only one
city was considerably greater than that reported in national
registries (Canfield et al, 2004; Linabery et al, 2006).
The protective effect of breastfeeding has been observed
principally for children of 5 years or younger, the age when the
peak incidence of AL occurs (Kwan et al, 2004) and when
breastfeeding has been proposed to have an immuno-modulating
effect (Kirsten and Morgan, 2008). We cannot explain why a
protective effect should only be evident for breastfeeding for 6
months of life or less, and not with longer periods, but it is relevant
that the effect is not statistically significant.
The finding that hospitalisations for infections during the first
year of life was a risk factor for ALL in children older than 6 years
with DS is a new finding. However, it is consistent with the report
by Roman et al (2007) that the infection during the first year of life
was a risk factor for ALL at ages 2–5 years, particularly when the
infection occurred during the first month of life. It may be relevant
that a study in Mexico City reported a double incidence peak for
AL, at 2–3 and 6–9 years of age (Bernaldez-Rios et al, 2008). If
infections during the first year of life are a genuine factor, our
findings may imply that in Mexico City these peaks have different
etiologies with infection being more important for the 6–9 years
age group. The relevant agents may be viewed as having an indirect
leukemogenic effect, as in situations reported in relation to cancer
in adults (Matsumoto et al, 2008).
That infectious agents are associated with the development of
AL in Mexico City is supported by the fact that (1) the incidence of
ALL is higher than in most developed countries, (2) infections are
also more prevalent and (3) lymphomas, which could also be
associated with infectious agents, have an earlier age of onset
among children in Mexico City than reported for developed
countries (Mejia-Arangure et al, 2005b). Although these arguments
must be assessed in other studies, our results do not support the
Greaves’s hypothesis that early infection is protective against
childhood ALL.
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